Pheno Therapeutics

Pheno Therapeutics is a clinical stage biotech company developing GPR17 antagonists for neurodegenerative and demyelinating disorders

Biotech & Life Sciences

Sector

Seed

Stage

Biotechnology

Model

01Company Overview

Pheno Therapeutics is a clinical stage biotech company developing GPR17 antagonists for neurodegenerative and demyelinating disorders.

02Backed By1 investor

03Recent Activity

FROM Advent Life Sciences

Portfolio company Pheno Therapeutics received FDA IND clearance for PTD802 in multiple sclerosis.

MILESTONE·adventls.com

JUN 22, 2026

04Similar Companies

PT

EP

CT

NT

E

05Startup DNA

10

signals

Sectors
Business Model
Technology